Charles H Yoon MD PhD
Melanoma, Surgical Oncology (Other than Breast)
Associate Surgeon, Brigham and Women's Hospital; Assistant Professor of Surgery, Harvard Medical School
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-5500
Fax+1 617-582-6177
Dr. Yoon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Complex General Surgical Oncology, 2007 - 2009
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2004 - 2007
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2001 - 2004
New York University School of MedicineClass of 2001
California Institute of TechnologyPh.D., Biology, 1991 - 1997
Certifications & Licensure
MA State Medical License 2007 - 2026
NH State Medical License 2023 - 2025
ME State Medical License 2022 - 2024
RI State Medical License 2022 - 2024
CT State Medical License 2022 - 2023
NY State Medical License 2003 - 2009
American Board of Surgery Surgery
American College of SurgeonsFellow of the American College of Surgeons
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Publications & Presentations
PubMed
- A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma.Eryn Blass, Derin B Keskin, Chloe R Tu, Cleo Forman, Allison Vanasse
Cell. 2025-07-09 - 1 citationsFirst-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell-Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic M...F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, Srin Ranasinghe, Ana Lako
Cancer Immunology Research. 2025-07-02 - Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial.Charles H Yoon, Merrick I Ross, Brian R Gastman, Jason J Luke, Paolo A Ascierto
Annals of Surgical Oncology. 2025-04-01
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish, Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
